835 GENES FOUND

Show / hide columns »

XML | RDF | TAB | « prev | Page of 17 | next »

BAIAP2L2BAI1-associated protein 2-like 2Predicted intracellular proteins
Tissue enhanced
BCAR1Breast cancer anti-estrogen resistance 1Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Plasma membrane
Cytosol
Mixed
BDH13-hydroxybutyrate dehydrogenase, type 1Candidate cardiovascular disease genes
Enzymes
Predicted intracellular proteins
MitochondriaTissue enriched
BIRC5Baculoviral IAP repeat containing 5Cancer-related genes
Predicted intracellular proteins
Cytokinetic bridgeTissue enhanced
BMP8ABone morphogenetic protein 8aPredicted secreted proteins
Tissue enriched
BRAFB-Raf proto-oncogene, serine/threonine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Vesicles
Cytosol
Expressed in all
BRAPBRCA1 associated proteinPredicted intracellular proteins
RAS pathway related proteins
Nuclear membrane
Cytosol
Tissue enriched
BRSK2BR serine/threonine kinase 2Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Golgi apparatusTissue enhanced
BSCL2Berardinelli-Seip congenital lipodystrophy 2 (seipin)Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
CAB39Calcium binding protein 39Plasma proteins
Predicted intracellular proteins
Nucleoli
Cytosol
Expressed in all
CAB39LCalcium binding protein 39-likePlasma proteins
Predicted intracellular proteins
VesiclesExpressed in all
CACNA1ACalcium channel, voltage-dependent, P/Q type, alpha 1A subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Golgi apparatus
Vesicles
Tissue enhanced
CACNA1DCalcium channel, voltage-dependent, L type, alpha 1D subunitCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Nuclear membraneMixed
CACNA2D2Calcium channel, voltage-dependent, alpha 2/delta subunit 2FDA approved drug targets
Predicted intracellular proteins
Transporters
VesiclesTissue enriched
CALM1Calmodulin 1 (phosphorylase kinase, delta)Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
RAS pathway related proteins
Transporters
VesiclesExpressed in all
CALM2Calmodulin 2 (phosphorylase kinase, delta)Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
RAS pathway related proteins
Transporters
Expressed in all
CALM3Calmodulin 3 (phosphorylase kinase, delta)Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
RAS pathway related proteins
Transporters
Expressed in all
CAMK2ACalcium/calmodulin-dependent protein kinase II alphaEnzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Plasma membrane
Cell Junctions
Tissue enriched
CAMK2BCalcium/calmodulin-dependent protein kinase II betaEnzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Plasma membrane
Cell Junctions
Tissue enhanced
CAMK2DCalcium/calmodulin-dependent protein kinase II deltaEnzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cell Junctions
Expressed in all
CARTPTCART prepropeptideFDA approved drug targets
Predicted secreted proteins
Tissue enriched
CASRCalcium-sensing receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched
CATCatalaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Vesicles
Cytosol
Expressed in all
CAV2Caveolin 2Predicted intracellular proteins
Predicted membrane proteins
VesiclesMixed
CCKARCholecystokinin A receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
CCL2Chemokine (C-C motif) ligand 2Cancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Expressed in all
CCL5Chemokine (C-C motif) ligand 5Cancer-related genes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD38CD38 moleculeCancer-related genes
CD markers
Enzymes
Predicted intracellular proteins
Plasma membraneMixed
CDK16Cyclin-dependent kinase 16Enzymes
Predicted intracellular proteins
Plasma membrane
Microtubules
Cytosol
Expressed in all
CDK2Cyclin-dependent kinase 2Cancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Centrosome
Cytosol
Expressed in all
CEP19Centrosomal protein 19kDaDisease related genes
Predicted intracellular proteins
CentrosomeTissue enhanced
CFDComplement factor D (adipsin)Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted secreted proteins
Plasma membraneTissue enriched
CFTRCystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
CHRM3Cholinergic receptor, muscarinic 3Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Plasma membraneTissue enhanced
CISHCytokine inducible SH2-containing proteinPredicted intracellular proteins
Microtubules
Cytokinetic bridge
Mixed
CITED1Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1Predicted intracellular proteins
Nucleoplasm
Cytosol
Tissue enriched
CLOCKClock circadian regulatorEnzymes
Predicted intracellular proteins
Transcription factors
NucleoplasmMixed
CNR1Cannabinoid receptor 1 (brain)FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membrane
Actin filaments
Tissue enhanced
CPEB1Cytoplasmic polyadenylation element binding protein 1Predicted intracellular proteins
Nucleoplasm
Vesicles
Tissue enhanced
CPEB2Cytoplasmic polyadenylation element binding protein 2Predicted intracellular proteins
Nucleoplasm
Cytosol
Tissue enhanced
CPLX1Complexin 1Predicted intracellular proteins
VesiclesTissue enriched
CPLX3Complexin 3Predicted intracellular proteins
Group enriched
CPT1ACarnitine palmitoyltransferase 1A (liver)Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
MitochondriaExpressed in all
CRHCorticotropin releasing hormonePlasma proteins
Predicted secreted proteins
Tissue enhanced
CRHR2Corticotropin releasing hormone receptor 2G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CRY1Cryptochrome circadian clock 1Predicted intracellular proteins
Nucleus
Nuclear membrane
Microtubules
Expressed in all
CRY2Cryptochrome circadian clock 2Predicted intracellular proteins
Predicted secreted proteins
Nuclear speckles
Cytosol
Expressed in all
CSF2Colony stimulating factor 2 (granulocyte-macrophage)Cancer-related genes
Predicted secreted proteins
VesiclesTissue enhanced
CSF2RAColony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CSF2RBColony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Golgi apparatusTissue enhanced

« prev | Page of 17 | next »